Journal profile · Obstetrics & Gynecology

Climacteric

ISSN 1369-7137 · eISSN 1473-0804 · Taylor and Francis Ltd. · ENGLAND · Quarterly · Founded 1998

Climacteric: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.9; hybrid open access; median 144 days to acceptance (92 articles, last 24 months); community-reported acceptance: about 50%; 114 articles in 2025; indexed in SCIE and Scopus.

Impact factor3.9Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time144 daysMedian, submission to acceptance · 92 articles, last 24 months · Crossref
APC—No source gives fee information
Acceptanceabout 50%Community average
Articles per year1142025 · OpenAlex count

Scope

Aims, scope and focus

Climacteric is published by Taylor and Francis Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Menopause: Health Impacts and Treatments, Estrogen and related hormone effects and Phytoestrogen effects and research, together about 52.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Climacteric is the official journal of the International Menopause Society (IMS). As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women. Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health. Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women. Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments. The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia. He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers.

Source: LetPub

Research area (LetPub): Obstetrics & Gynecology

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Menopause: Health Impacts and TreatmentsMedicine30.7%
  2. Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology14.7%
  3. Phytoestrogen effects and researchMedicine7%
  4. Bone health and osteoporosis researchMedicine5%
  5. Sexual function and dysfunction studiesMedicine4.3%
  6. Hormonal and reproductive studiesMedicine4.2%
  7. Sex and Gender in HealthcareMedicine3.6%
  8. Cancer Risks and FactorsMedicine3.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorObstetrics & GynecologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorObstetrics & GynecologyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorObstetrics & GynecologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
3.9LetPub ·
CiteScore 2026-06
7LetPub ·
SJR 2026-06
1.09LetPub ·
SNIP 2026-06
1.39LetPub ·
h-index
62LetPub ·
h-index
103OpenAlex ·
i10-index
1,499OpenAlex ·
2-year mean citedness
4.09OpenAlex ·
Self-citation rate
12.8%LetPub ·
Share of gold OA articles
17.86%LetPub ·

Volume

Articles per year
98LetPub ·

Articles by year OpenAlex count · 2,828 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026822938
202511450376
20248140718
2023105461,112
202256221,043
2021111381,965

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

144 daysMedian, submission to acceptance · P25–P75 99 days – 197 days

Acceptance to online
median 33 days (92 articles)
Submission to online
median 177 days
Sample
92 articles with submission and acceptance dates (214 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 1 monthLetPub ·
Average acceptance (community reports)
50%LetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Taylor and Francis Ltd.
Country or region
ENGLAND
Language
English
Frequency
Quarterly
Founded
1998
ISSN
1369-7137
Electronic ISSN
1473-0804
Official links

FAQ

Frequently asked questions about Climacteric

What CAS zone is Climacteric in?

In the 2025 upgraded edition of the CAS Journal Ranking, Climacteric is in Zone 4 of Medicine, and in Zone 4 of the minor category Obstetrics & Gynecology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Climacteric?

The latest impact factor listed by LetPub is 3.9; CiteScore 7, h-index 103.

How long does peer review take at Climacteric?

Based on the dates recorded on 92 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 144 days (interquartile range 99–197 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Climacteric?

According to LetPub and DOAJ records, Climacteric is indexed in SCIE and Scopus.

Is Climacteric open access, and what is the APC?

Climacteric is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .